Allergy Therapeutics (AGY)
12/12/2017 - 07:49 StockMarketWire
Allergy Therapeutics has entered into a co-development collaboration agreement with Ergomed for the clinical developme...
12/12/2017 - 07:00 RNS
RNS Number: 0248Z Allergy Therapeutics PLC 12 December 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Allergy Therapeutics enters co-development agreement with Ergomed plc 12 December 2017 Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, today announces it h...
07/12/2017 - 17:08 RNS
RNS Number: 7505Y Allergy Therapeutics PLC 07 December 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Allergy ...
22/11/2017 - 13:56 StockMarketWire
Allergy Therapeutics has announced that all resolutions were passed by shareholders at today's Annual General Meeting. A...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment